Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- GSK Launches New OTC Sleep Inducer
March 12, 2007
- Nippon Organon to Launch a Series of Major New Products: Mr van Eerd
March 12, 2007
- SELF-MEDICATION NEWS IN BRIEF
March 12, 2007
- Preminent Maintains Top Position: Rep Track Survey
March 12, 2007
- Pfizer Japan Needs Flat, Agile Organization: Mr Iwasaki
March 12, 2007
- DSM to Expand Its Business in Life Sciences
March 12, 2007
- BUSINESS NEWS IN BRIEF
March 12, 2007
- APDD Kicks Off Symposium on Microdosing Studies ―１―
March 12, 2007
- APDD Kicks Off Symposium on Microdosing Studies ―２―
March 12, 2007
- Post-Marketing Clinical Trials to Increase: JCROA Seminar
March 12, 2007
- R&D NEWS IN BRIEF
March 12, 2007
- Prefectural Health Policy Officials' Conference
March 12, 2007
- Novartis Cautions against Off-label Use of Femara
March 12, 2007
- Keep an Eye on Children after Administering Tamiflu: Korosho
March 12, 2007
- Thai Gov't Exercises Compulsory License
March 12, 2007
- REGULATORY NEWS IN BRIEF
March 12, 2007
- Prefectures Generally Unenthusiastic about Promoting Use of Generics
March 5, 2007
- Vesicare Leads Market for Pollakisuria, Urinary Incontinence
March 5, 2007
- Ohara Pharm. Aims for Sales of \10 Bil. in FY2009
March 5, 2007
- Approval of Western Herbs as OTC Drugs Becoming Reality: JSMI
March 5, 2007
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…